140 related articles for article (PubMed ID: 7696971)
1. IL-11, a pleiotropic cytokine: exciting new effects of IL-11 on gastrointestinal mucosal biology.
Keith JC; Albert L; Sonis ST; Pfeiffer CJ; Schaub RG
Stem Cells; 1994; 12 Suppl 1():79-89; discussion 89-90. PubMed ID: 7696971
[TBL] [Abstract][Full Text] [Related]
2. Molecular effects of recombinant human interleukin-11 in the HLA-B27 rat model of inflammatory bowel disease.
Peterson RL; Wang L; Albert L; Keith JC; Dorner AJ
Lab Invest; 1998 Dec; 78(12):1503-12. PubMed ID: 9881950
[TBL] [Abstract][Full Text] [Related]
3. Oral treatment with recombinant human interleukin-11 improves mucosal transport in the colon of human leukocyte antigen-B27 transgenic rats.
Venkova K; Keith JC; Greenwood-Van Meerveld B
J Pharmacol Exp Ther; 2004 Jan; 308(1):206-13. PubMed ID: 14569059
[TBL] [Abstract][Full Text] [Related]
4. Pharmacogenomic analysis of rhIL-11 treatment in the HLA-B27 rat model of inflammatory bowel disease.
Peterson RL; Wang L; Albert L; Marchese E; Erickson J; Wong A; Mounts WM; Hayes L; Bouchard P; Keith J; Dorner AJ
Pharmacogenomics J; 2002; 2(6):383-99. PubMed ID: 12629504
[TBL] [Abstract][Full Text] [Related]
5. Effects of murine recombinant interleukin-10 on the inflammatory disease of rats transgenic for HLA-B27 and human beta 2-microglobulin.
Bertrand V; Quéré S; Guimbaud R; Sogni P; Chauvelot-Moachon L; Tulliez M; Lamarque D; Charreire J; Giroud JP; Couturier D; Chaussade S; Breban M
Eur Cytokine Netw; 1998 Jun; 9(2):161-70. PubMed ID: 9681392
[TBL] [Abstract][Full Text] [Related]
6. Recombinant human interleukin-11 restores smooth muscle function in the jejunum and colon of human leukocyte antigen-B27 rats with intestinal inflammation.
Greenwood-Van Meerveld B; Venkova K; Keith JC
J Pharmacol Exp Ther; 2001 Oct; 299(1):58-66. PubMed ID: 11561063
[TBL] [Abstract][Full Text] [Related]
7. Mitigating effects of interleukin 11 on consecutive courses of 5-fluorouracil-induced ulcerative mucositis in hamsters.
Sonis ST; Van Vugt AG; McDonald J; Dotoli E; Schwertschlag U; Szklut P; Keith J
Cytokine; 1997 Aug; 9(8):605-12. PubMed ID: 9245489
[TBL] [Abstract][Full Text] [Related]
8. Recombinant human interleukin-11 modulates ion transport and mucosal inflammation in the small intestine and colon.
Greenwood-Van Meerveld B; Tyler K; Keith JC
Lab Invest; 2000 Aug; 80(8):1269-80. PubMed ID: 10950118
[TBL] [Abstract][Full Text] [Related]
9. Treatment of inflammatory bowel disease in a rodent model with the intestinal growth factor glucagon-like peptide-2.
Alavi K; Schwartz MZ; Palazzo JP; Prasad R
J Pediatr Surg; 2000 Jun; 35(6):847-51. PubMed ID: 10873024
[TBL] [Abstract][Full Text] [Related]
10. Dose-dependent effects of recombinant human interleukin-11 on contractile properties in rabbit 2,4,6-trinitrobenzene sulfonic acid colitis.
Depoortere I; Thijs T; van Assche G; Keith JC; Peeters TL
J Pharmacol Exp Ther; 2000 Sep; 294(3):983-90. PubMed ID: 10945850
[TBL] [Abstract][Full Text] [Related]
11. Effect of granulocyte macrophage-colony stimulating factor (GM-CSF) on 5-FU-induced ulcerative mucositis in hamster buccal pouches.
Cho SA; Park JH; Seok SH; Juhn JH; Kim SJ; Ji HJ; Choo YS; Park JH
Exp Toxicol Pathol; 2006 Mar; 57(4):321-8. PubMed ID: 16414253
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-11 prevents apoptosis and accelerates recovery of small intestinal mucosa in mice treated with combined chemotherapy and radiation.
Orazi A; Du X; Yang Z; Kashai M; Williams DA
Lab Invest; 1996 Jul; 75(1):33-42. PubMed ID: 8683938
[TBL] [Abstract][Full Text] [Related]
13. Local administration of interleukin-11 ameliorates intestinal radiation injury in rats.
Boerma M; Wang J; Burnett AF; Santin AD; Roman JJ; Hauer-Jensen M
Cancer Res; 2007 Oct; 67(19):9501-6. PubMed ID: 17909060
[TBL] [Abstract][Full Text] [Related]
14. Effect of DA-6034, a derivative of flavonoid, on experimental animal models of inflammatory bowel disease.
Kim YS; Son M; Ko JI; Cho H; Yoo M; Kim WB; Song IS; Kim CY
Arch Pharm Res; 1999 Aug; 22(4):354-60. PubMed ID: 10489873
[TBL] [Abstract][Full Text] [Related]
15. Increased tissue protein synthesis during spontaneous inflammatory bowel disease in HLA-B27 rats.
El Yousfi M; Breuillé D; Papet I; Blum S; André M; Mosoni L; Denis P; Buffière C; Obled C
Clin Sci (Lond); 2003 Oct; 105(4):437-46. PubMed ID: 12793856
[TBL] [Abstract][Full Text] [Related]
16. Amelioration of chronic and spontaneous intestinal inflammation with an antisense oligonucleotide (ISIS 9125) to intracellular adhesion molecule-1 in the HLA-B27/beta2 microglobulin transgenic rat model.
Bowen-Yacyshyn MB; Bennett CF; Nation N; Rayner D; Yacyshyn BR
J Pharmacol Exp Ther; 2002 Sep; 302(3):908-17. PubMed ID: 12183646
[TBL] [Abstract][Full Text] [Related]
17. Recombinant human interleukin-11 prevents mucosal atrophy and bowel shortening in the defunctionalized intestine.
Dickinson EC; Tuncer R; Nadler EP; Koltuksuz U; Boyle P; Alber SM; Watkins SC; Ford HR
J Pediatr Surg; 2000 Jul; 35(7):1079-83. PubMed ID: 10917300
[TBL] [Abstract][Full Text] [Related]
18. Effects of interleukin-11 and epidermal growth factor on residual small intestine after experimental massive small bowel resection.
Ledniczky G; Fiore N; Bognár G; Ondrejka P; Grosfeld JL
Chirurgia (Bucur); 2006; 101(2):127-33. PubMed ID: 16752677
[TBL] [Abstract][Full Text] [Related]
19. Gastrointestinal mucosal injury following repeated daily oral administration of conventional formulations of indometacin and other non-steroidal anti-inflammatory drugs to pigs: a model for human gastrointestinal disease.
Rainsford KD; Stetsko PI; Sirko SP; Debski S
J Pharm Pharmacol; 2003 May; 55(5):661-8. PubMed ID: 12831509
[TBL] [Abstract][Full Text] [Related]
20. Susceptibility to inflammatory disease in HLA-B27 transgenic rat lines correlates with the level of B27 expression.
Taurog JD; Maika SD; Simmons WA; Breban M; Hammer RE
J Immunol; 1993 May; 150(9):4168-78. PubMed ID: 8473755
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
